STOCKHOLM, June 1, 2018 /PRNewswire/ -- Cyxone AB (publ) announced today that the company has decided to complete the acquisition of drug candidate Rabeximod and issue approximately 1.9 million shares to complete the payment to OxyPharma AB. Cyxone entered into an acquisition agreement...
from PR Newswire: //https://ift.tt/2Jo31Jh
No comments:
Post a Comment